MWNA
ORGO icon

Marshall Wace North America’s Organogenesis Holdings ORGO Stock Holding History

Marshall Wace North America’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$848K Buy
+59,534
New +$924K ﹤0.01% 982
2021
Q2 		– Sell
-72,909
Closed -$1.33M – 1676
2021
Q1 		$1.33M Buy
72,909
+32,403
+80% +$439K 0.01% 949
2020
Q4 		$305K Buy
+40,506
New +$192K ﹤0.01% 1168

Other funds holding ORGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
NMIMC
Northwestern Mutual Investment Management Company Milwaukee, Wisconsin $8.53B AUM 25.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Marshall Wace North America's ORGO Position: Q3 2021 in Review

Marshall Wace North America opened a new position in Organogenesis Holdings (ORGO) in Q3 2021: 59,534 shares worth $848K. The stake represents ﹤0.01% of the portfolio and ranks #982 among its holdings. This is a return to the name: Marshall Wace North America previously reported a position in ORGO as recently as Q1 2021.

Marshall Wace North America first reported a position in ORGO in Q4 2020 and has held it in 3 quarters since. The position peaked at $1.33M in Q1 2021. 153 funds tracked by Wall St. Rank hold ORGO as of Q3 2021.

  • Marshall Wace North America held 59,534 shares of Organogenesis Holdings worth $848K as of Q3 2021.
  • Organogenesis Holdings was a new Marshall Wace North America position in Q3 2021.
  • Organogenesis Holdings made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #982 holding.
  • Marshall Wace North America first reported a position in Organogenesis Holdings in Q4 2020 and has held it in 3 quarters since.
  • Marshall Wace North America's Organogenesis Holdings position peaked at $1.33M in Q1 2021.
  • 153 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.